Cutaneous Drug Eruptions in Pediatrics-A Primer

Area of Science:

• Pediatric Dermatology
• Pharmacovigilance
• Clinical Toxicology

Background:

• Cutaneous adverse drug reactions (ADRs) are frequent in pediatric patients across various healthcare settings.
• Accurate diagnosis and classification of cutaneous ADRs are crucial for clinical decision-making.
• Identifying the causative agent and determining medication safety are key management goals.

Purpose of the Study:

• To review the clinical presentation of cutaneous ADRs in children.
• To discuss the categorization and classification systems for pediatric cutaneous ADRs.
• To outline appropriate management strategies for cutaneous ADRs in the pediatric population.

Main Methods:

• Literature review of pediatric cutaneous adverse drug reactions.
• Synthesis of information on clinical presentation and classification.
• Compilation of current management guidelines.

Main Results:

• Cutaneous ADRs manifest in diverse ways in children.
• Systematic classification aids in identifying culprit medications.
• Management strategies focus on drug withdrawal and symptomatic treatment.

Conclusions:

• Early recognition and accurate classification of pediatric cutaneous ADRs are essential.
• Effective management ensures patient safety and optimizes therapeutic outcomes.
• This review provides a framework for clinicians managing pediatric cutaneous ADRs.